프로단백질 전환효소 서브틸리신/켁신 타입 1(PCSK1) 변이체 및 그 용도

비만을 치료하는 방법 및 렙틴-멜라노코르틴 신호전달 경로의 작용제를 사용하여 치료할 비만 대상체의 민감성을 식별하는 방법이 본원에 제공된다. Methods of treating obesity and methods of identifying susceptibility of an obese subject to treatment with an agonist of the leptin-melanocortin signaling pathway are provided herein....

Full description

Saved in:
Bibliographic Details
Main Authors LOTTA LUCA ANDREA, FERREIRA MANUEL ALLEN REVEZ
Format Patent
LanguageKorean
Published 09.02.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:비만을 치료하는 방법 및 렙틴-멜라노코르틴 신호전달 경로의 작용제를 사용하여 치료할 비만 대상체의 민감성을 식별하는 방법이 본원에 제공된다. Methods of treating obesity and methods of identifying susceptibility of an obese subject to treatment with an agonist of the leptin-melanocortin signaling pathway are provided herein.
Bibliography:Application Number: KR20227042440